ATS Management Commentary Attributes Q2 Fiscal 2027 Net Loss to Lower Revenues

• ATS management commentary attributed second-quarter fiscal 2027 revenue decline of 8.6% to CAD 665.8 million to normalized GLP-1 activity and non-life-sciences weakness.
• Lower volumes and business mix reduced adjusted operating earnings 27.4% to CAD 57.4 million; adjusted operating margin fell to 8.6%.
• Net loss reached CAD 5 million, compared with CAD 33.6 million net income a year earlier, primarily reflecting lower revenue.
• Order delays exacerbated by tariff uncertainty put previous annual revenue-growth and margin-expansion goals out of reach; third-quarter revenue forecast: CAD 640 million–680 million.
• Order bookings rose 12.7% to CAD 827 million, primarily reflecting large enterprise orders, partly offset by lower nuclear refurbishment activity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ATS Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001394832-26-000028), on November 04, 2026, and is solely responsible for the information contained therein.